Viewing nowSarel SR Tablet (Sarpogrelate Hydrochloride)
Sarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

MFDS item code 201903478 · Approved 2019.05.28 · Insurance code 621803720
Improvement of ischemic symptoms related to chronic arterial occlusion (ulcer, pain, etc.)
This medicine is used to improve symptoms such as ulcers, pain, and coldness caused by ischemic conditions related to chronic arterial occlusion, such as Buerger's disease, occlusive arterial sclerosis, and diabetic peripheral vascular disease.
Administer a Sarpogrelate Hydrochloride sustained-release tablet of 300 mg orally once daily after meals. This medication should be taken whole and not chewed or crushed.
This medicine should not be administered to patients with bleeding. This is because it can exacerbate bleeding in conditions with a high risk of bleeding, such as hemophilia or gastrointestinal ulcers. It is safe for pregnant women or women who may become pregnant to avoid this drug, as negative effects on the fetus have been reported in animal studies. Women who are menstruating or have a tendency to bleed should use this drug with caution as the risk of bleeding may increase. Patients taking anticoagulants or antiplatelet drugs should be cautious when using this drug together as it may increase the risk of bleeding. Patients with severely impaired kidney function or the elderly should be closely monitored when taking this medication, as it can affect bodily functions. Various adverse reactions such as urticaria, dyspepsia, headache, and cough may occur during treatment with this drug, so one's condition should be closely observed. In particular, if symptoms of bleeding, blood disorders, or liver dysfunction appear, it is important to consult with medical personnel immediately and discontinue use if necessary. Regular blood tests to check for adverse reactions are recommended. It is advisable for pregnant or breastfeeding women to avoid using this medication, and if unavoidable, it is preferable to abstain from breastfeeding. Safety in pediatric patients has not been established, so it is best to avoid use in children. This medicinal product should be stored out of reach of children, and it is important not to transfer it to other containers to maintain quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. The best storage temperature is between 1 to 30 degrees Celsius.
White, rectangular, film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSarpogrelate Hydrochloride 200mg
Tablet · Prescription medication
Korea Pavis Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Yuhan Corporation

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Korea United Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
(Co., Ltd.) Pharmgen Science

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Dongkook Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Haewon Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Sarpogrelate Hydrochloride 100mg
Tablet · Prescription medication
Allico Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.